Oxidative Medicine and Cellular Longevity / 2011 / Article / Tab 2

Research Article

Evaluation of Chromosomal Instability in Diabetic Rats Treated with Naringin

Table 2

Frequencies of micronucleated polychromatic erythrocytes (% MNPCE) and mitotic activity (% PCE) in bone marrow of nondiabetic and diabetic rats 24 hours after the last treatment with the indicated doses of naringin (4 weeks exposures, spaced 24 hours apart) (mean ± SD).

Treatment groups (mg/kg)% MNPCE (mean ± SD)% PCE (mean ± SD)

Nondiabetic control0.32 ± 0.0848.4 ± 1.81
Nondiabetic + naringin (25)0.30 ± 0.0748.2 ± 2.16
Nondiabetic + naringin (50)0.28 ± 0.0849.0 ± 1.41
Diabetes0.92 ± 0.13**45.6 ± 3.97
Diabetes + naringin (25)0.60 ± 0.12a47.0 ± 2.54
Diabetes + naringin (50)0.44 ± 0.11b47.4 ± 2.40

versus nondiabetic control (Kruskal-Wallis test followed by Dunn’s multiple comparisons test). a and b versus diabetes alone (Mann-Whitney U test).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.